PENTACEF (CEFTAZIDIME) — FDA Approval ANDA063322 (GLAXOSMITHKLINE)
PENTACEF (CEFTAZIDIME) — FDA Approval ANDA063322 (GLAXOSMITHKLINE) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: PENTACEF; Active ingredients: CEFTAZIDIME; Application number: ANDA063322.
| Brand name | PENTACEF |
|---|---|
| Active ingredients | CEFTAZIDIME |
| Application number | ANDA063322 |
| Sponsor | GLAXOSMITHKLINE |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Discontinued |
| Products in application | 2 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →